Current position

Terry Smith’s Medpace Hldgs Inc (MEDP) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Fundsmith LLPVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ4 2024Earliest verified positive filing snapshot
Latest statusCurrent positionBased on the latest supported relationship state
Peak shares127.54KHighest verified quarter-end share count
Quarters reported7Verified quarters with shares above zero
What happened?

Fundsmith LLP first reported Medpace Hldgs Inc in Q4 2024. The reported position was reduced across later filings. Fundsmith LLP currently reports 52.37K shares. The latest verified filing showed: Sold 16.4% of the position.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q2 2026
Sold 16.4% of the position−10.30K shares · 52.37K shares remained
Filing context

Quarter-end price $529.59 · Estimated holding basis $332.23

Q1 2026
Sold 24.1% of the position−19.90K shares · 62.67K shares remained
Filing context

Quarter-end price $480.19 · Estimated holding basis $332.23

Q4 2025
Sold 35.3% of the position−44.97K shares · 82.57K shares remained
Filing context

Quarter-end price $561.65 · Estimated holding basis $332.23

Q4 2024
New position+127.54K shares · 127.54K shares reported
Filing context

Quarter-end price $332.23 · Estimated holding basis $332.23

3 unchanged quarters are collapsed by default.

Portfolio importance

How important is Medpace Hldgs Inc in Fundsmith LLP’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Current portfolio weight0.2%Q2 2026
Current rank#26of 41 reported positions
Peak portfolio weight0.3%Q3 2025
Best historical rank#20Q1 2026
At peak importanceQ3 2025
MEDP
0.3%
Largest holding
8.6%
Cross-investor discovery

Who else owns Medpace Hldgs Inc?

Also reported by 2 other tracked investors in their latest verified filings.

Joel GreenblattGotham Asset Management
MEDP0.0% of reported portfolio
Ray DalioBridgewater Associates, LP
MEDP0.0% of reported portfolio
Explore Medpace Hldgs Inc across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$587.522026-09-11

Market context only; not an investor transaction price.

Latest filing quarter-end price$529.59Q2 2026

Derived from validated reported value and shares where supported.

Estimated holding basis$332.23Historical reference — not actual purchase price

Calculated from supported filing history.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

This tracker follows Fundsmith LLP’s reported positions. Form 13F reports quarter-end positions and is filed later; it does not disclose exact trade dates or execution prices.